Collaborating on new therapies for hypoplastic left heart syndrome
Children’s Minnesota and Mayo Clinic recently announced a formal collaboration focused on developing new treatments to prevent heart failure for hypoplastic left heart syndrome (HLHS), a rare form of congenital heart disease in which the left side of a child’s heart is severely underdeveloped.
